substernal epicardial echocardiography in a patient undergoing left ventricular assist device a case report胸骨下的心外膜超声心动图在病人接受左心室辅助装置一个案例报告.pdfVIP

Available online /supplements/6/S2 Critical Care Volume 6 Supplement 2, 2002 19th Spring Meeting of the Association of Cardiothoracic Anaesthetists: selected abstracts Cambridge, UK, 21 June 2002 Association of Cardiothoracic Anaesthetists Published online: 9 July 2002 This article is online at /supplements/6/S2 © 2002 BioMed Central Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X) The publication of these abstracts was made possible by an unrestricted educational grant from Bayer plc 1 A survey of non-depolarising muscle relaxants used in cardiac anaesthesia and surgery S Briggs, R Thomas, P Goodyear, D Smith Department of Anaesthesia, Southampton University Hospitals NHS Trust, Tremona Road, Southampton SO16 6YD, UK Critical Care 2002, 6 (Suppl 2):1 Introduction: Residual neuromuscular blockade contributes to comparison could be made) changed their choice of NDMR postoperative morbidity and mortality, and is more common with between NFT and FT patients. The majority of these anaesthetists long-acting non-depolarising muscle relaxants (NDMRs) such as (85.7%) remove pancuronium from their practice for FT patients. pancuronium [1]. This phenomenon may be a common occurrence Of respondents, 20.7% (45/217) indicated that an assessment of in ‘fast-track’ managed cardiac patients administered long-acting neuromuscular function was part of an extubation protocol; 75.6% NDMRs. We examine the usage of NDMRs in cardiac anaesthesia (34/45) of these respondents detailed only clinical methods, whilst in the United Kingdom. 6.7% (3/45) indicated use of a ‘neuromuscular function monitor’